Why It Matters
Stop Gas Station Heroin LLC is lobbying on kratom regulation as federal agencies move to restrict access. The Food and Drug Administration (FDA) issued a consumer warning in May 2025 about tianeptine products, often sold alongside kratom. The U.S. Drug Enforcement Administration (DEA) filed its intent to temporarily place related substances into Schedule I, or high potential for abuse, July 1. Relevant bills like H.R. 7407 and S. 3797 would prohibit tianeptine from being introduced into interstate commerce as a dietary supplement.
"Stop Gas Station Heroin advocates for stronger regulation of dangerous concentrated synthetic 7-hydroxymitragynine products," a spokesperson for Marathon Strategies on behalf of Stop Gas Station Heroin told Legis1. "Its work is focused on protecting consumers and establishing a clear regulatory distinction between these products and unenhanced natural kratom leaf."
By the Numbers
Checkmate Government Relations LLC filed a second quarter 2026 lobbying report for Stop Gas Station Heroin LLC for $150,000. The engagement spans multiple quarters: third quarter of 2025 at $150,000, fourth quarter of 2025 at $300,000, and first quarter of 2026 at $150,000, totaling $750,000 across the engagement. The team includes five active lobbyists: Ches McDowell IV, Caitlin Koury, Usman Rahim, Luke Blanchat, and Teresa Morgenstern.
The Bottom Line
Stop Gas Station Heroin LLC has maintained consistent lobbying spending on kratom regulation through changing federal oversight. The addition of two new lobbyists, Luke Blanchat and Teresa Morgenstern, in the second quarter and the team's prior government experience suggests a Capitol Hill-focused strategy.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article